OEC Orion SA posts far wider Q4 2025 loss than estimates as shares rise on positive investor sentiment KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today FRD Friedman Industries stock gains 414 percent following the release of its Q3 2024 earnings report FHI Federated Hermes posts 153 Q4 2025 EPS beat while shares dip 108 in todays trading Amgen Inc AMGN Stem Cell Therapy Leadership Meets Balanced NearTerm Valuation Dynamics